Healthcare
AcuamarkDX – SUCCESS PAGE – June 17, 2025
AcuamarkDX has developed a blood-based cancer detection platform for all stage 1 and 2 cancers where survival rates are highest.
AcuamarkDX has developed a blood-based cancer detection platform for all stage 1 and 2 cancers where survival rates are highest.
AcuamarkDX has developed a blood-based cancer detection platform for all stage 1 and 2 cancers where survival rates are highest.
Valinor ApS has developed what may be the most significant and valuable advancement in cancer therapy in the past 50 years.
Valinor ApS has developed what may be the most significant and valuable advancement in cancer therapy in the past 50 years.
Adora Life Science is unlocking the potential of a drug that can slow the progression of degenerative joint disease.
Adora Life Science is unlocking the potential of a drug that can slow the progression of degenerative joint disease.
Bryn is developing a new epinephrine nasal spray that improves on the EpiPen in a number of ways. Most importantly, there are no needles.
Bryn is developing a new epinephrine nasal spray that improves on the EpiPen in a number of ways. Most importantly, there are no needles.
SQ Innovation has developed a novel drug-device combination for treating fluid overload in adult patients with chronic heart failure
Cellibre has developed a platform technology to produce chemicals creating less expensive, higher quality, and more resilient supply chains.
SQ Innovation has developed a novel drug-device combination for treating fluid overload in adult patients with chronic heart failure
Cellibre has developed a platform technology to produce chemicals creating less expensive, higher quality, and more resilient supply chains.